Charles A. Rowland Jr - Jun 14, 2023 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Director
Signature
/s/ Frank Thomas, as attorney-in-fact
Stock symbol
ORTX
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 04:30 PM
Previous filing
Jun 12, 2023
Next filing
Dec 5, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares.